Sequence Detail

ID/Version

P18181 Q545K2 (UniProt | EBI)

Last sequence update: 1990-11-01
Last annotation update: 2024-03-27

Sequence description from provider

RecName: Full=CD48 antigen;AltName: Full=BCM1 surface antigen;AltName: Full=BLAST-1;AltName: Full=HM48-1;AltName: Full=MRC OX-45 surface antigen;AltName: Full=SLAM family member 2; Short=SLAMF2;AltName: Full=Signaling lymphocytic activation molecu

Provider

SWISS-PROT

Sequence

Polypeptide 240 aa

Source

Organism mouse

See UniProt | EBI for source

Annotated genes and markers

Follow the symbol links to get more information on the GO terms, expression assays, orthologs, phenotypic alleles, and other information for the genes or markers below.

Type	Symbol	Name	GO Terms	Expression Assays	Orthologs	Phenotypic Alleles
Gene	Cd48	CD48 antigen	10	98	3	11

Sequence references in MGI

J:2873 Kato K, et al., CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med. 1992 Nov 1;176(5):1241-9
J:10552 Wong YW, et al., Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3. J Exp Med. 1990 Jun 1;171(6):2115-30
J:99680 The FANTOM Consortium and RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group), The Transcriptional Landscape of the Mammalian Genome. Science. 2005;309(5740):1559-1563
J:126127 Velikovsky CA, et al., Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity. 2007 Oct;27(4):572-84
J:168539 Keszei M, et al., Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice. Int Immunol. 2011 Feb;23(2):149-58
J:292518 Huttlin EL, et al., A tissue-specific atlas of mouse protein phosphorylation and expression. Cell. 2010 Dec 23;143(7):1174-89